Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tony Butler is an analyst at Rodman & Renshaw. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 06/28/2024 | MURA | Buy Now | Mural Oncology | $3.02 | 396.69% | → $15 | Initiates | → Buy | Get Alert |
| 06/28/2024 | LPTX | Buy Now | Leap Therapeutics | $2.01 | 298.05% | → $8 | Initiates | → Buy | Get Alert |
| 08/10/2023 | ADAP | Buy Now | Adaptimmune Therapeutics | $1.15 | 769.79% | → $10 | Reiterates | Buy → Buy | Get Alert |
| 08/10/2023 | IPSC | Buy Now | Century Therapeutics | $2.30 | 595.65% | → $16 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2023 | FATE | Buy Now | Fate Therapeutics | $3.10 | 222.58% | → $10 | Reiterates | Buy → Buy | Get Alert |
| 08/08/2023 | CRSP | Buy Now | CRISPR Therapeutics | $53.65 | 39.79% | → $75 | Reiterates | Buy → Buy | Get Alert |
| 08/08/2023 | MRUS | Buy Now | Merus | $55.71 | -37.17% | → $35 | Reiterates | Buy → Buy | Get Alert |
| 08/07/2023 | GTBP | Buy Now | GT Biopharma | $2.65 | -24.53% | → $60 | Reiterates | Hold → Hold | Get Alert |
| 08/07/2023 | CGEN | Buy Now | Compugen | $1.64 | 693.02% | → $13 | Reiterates | Buy → Buy | Get Alert |
| 08/03/2023 | ALLO | Buy Now | Allogene Therapeutics | $2.24 | 569.64% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 08/03/2023 | BCYC | Buy Now | Bicycle Therapeutics | $20.23 | 147.16% | → $50 | Reiterates | → Buy | Get Alert |
| 08/03/2023 | ARAV | Buy Now | Aravive | — | — | — | Downgrade | Buy → Hold | Get Alert |
| 08/02/2023 | GTHX | Buy Now | G1 Therapeutics | $2.58 | 636.43% | → $19 | Reiterates | → Buy | Get Alert |
| 08/02/2023 | BCAB | Buy Now | BioAtla | $1.37 | 1724.82% | → $25 | Reiterates | Buy → Buy | Get Alert |
| 08/01/2023 | BMEA | Buy Now | Biomea Fusion | $4.80 | 795.83% | → $43 | Reiterates | Buy → Buy | Get Alert |
| 07/31/2023 | PYXS | Buy Now | Pyxis Oncology | $2.87 | 422.65% | → $15 | Initiates | → Buy | Get Alert |
| 07/31/2023 | VIRX | Buy Now | Viracta Therapeutics | $0.48 | 1983.33% | → $10 | Initiates | → Buy | Get Alert |
| 07/25/2023 | BMEA | Buy Now | Biomea Fusion | $4.80 | 795.83% | → $43 | Reiterates | Buy → Buy | Get Alert |
| 07/18/2023 | MRUS | Buy Now | Merus | $55.71 | -37.17% | → $35 | Reiterates | Buy → Buy | Get Alert |
| 07/12/2023 | BMEA | Buy Now | Biomea Fusion | $4.80 | 795.83% | → $43 | Reiterates | Buy → Buy | Get Alert |
| 07/12/2023 | CVM | Buy Now | CEL-SCI | $1.23 | 713.01% | → $10 | Reiterates | Buy → Buy | Get Alert |
| 07/07/2023 | CALC | Buy Now | CalciMedica | $4.25 | 300% | → $17 | Reiterates | Buy → Buy | Get Alert |
| 07/03/2023 | AGEN | Buy Now | Agenus | $15.56 | -46.66% | → $166 | Reiterates | Buy → Buy | Get Alert |
| 06/26/2023 | SVA | Buy Now | Sernova | $5.85 | -14.53% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2023 | CALC | Buy Now | CalciMedica | $4.25 | 300% | → $17 | Initiates | → Buy | Get Alert |
| 06/09/2023 | CRSP | Buy Now | CRISPR Therapeutics | $53.65 | 39.79% | → $75 | Reiterates | → Buy | Get Alert |
| 06/07/2023 | REPL | Buy Now | Replimune Group | $8.44 | 610.9% | → $60 | Reiterates | Buy → Buy | Get Alert |
| 06/06/2023 | CGEN | Buy Now | Compugen | $1.64 | 693.02% | → $13 | Reiterates | → Buy | Get Alert |
| 06/05/2023 | ARAV | Buy Now | Aravive | — | — | → $10 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | ALLO | Buy Now | Allogene Therapeutics | $2.24 | 569.64% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | AGEN | Buy Now | Agenus | $15.56 | -46.66% | → $166 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | ADAP | Buy Now | Adaptimmune Therapeutics | $1.15 | 769.79% | → $10 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | INAB | Buy Now | IN8bio | $0.82 | 872.64% | → $8 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | REPL | Buy Now | Replimune Group | $8.44 | 610.9% | → $60 | Reiterates | Buy → Buy | Get Alert |
| 06/02/2023 | ADAP | Buy Now | Adaptimmune Therapeutics | $1.15 | 769.79% | → $10 | Reiterates | → Buy | Get Alert |
| 06/01/2023 | VNRX | Buy Now | VolitionRX | $0.61 | 880.39% | → $6 | Assumes | → Buy | Get Alert |
| 06/01/2023 | HCWB | Buy Now | HCW Biologics | $0.62 | 1351.85% | → $9 | Assumes | → Buy | Get Alert |
| 05/30/2023 | RAIN | Buy Now | Rain Oncology | — | — | $5 → $2 | Maintains | Hold | Get Alert |
| 05/26/2023 | ARAV | Buy Now | Aravive | — | — | → $10 | Reiterates | Buy → Buy | Get Alert |
| 05/26/2023 | ALLO | Buy Now | Allogene Therapeutics | $2.24 | 569.64% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 05/26/2023 | AGEN | Buy Now | Agenus | $15.56 | -46.66% | → $166 | Reiterates | Buy → Buy | Get Alert |
| 05/26/2023 | ADAP | Buy Now | Adaptimmune Therapeutics | $1.15 | 769.79% | → $10 | Reiterates | → Buy | Get Alert |
| 05/26/2023 | APGN | Buy Now | Apexigen | — | — | → $0.64 | Reiterates | Hold → Hold | Get Alert |
| 05/26/2023 | CGEN | Buy Now | Compugen | $1.64 | 693.02% | → $13 | Reiterates | Buy → Buy | Get Alert |
| 05/26/2023 | REPL | Buy Now | Replimune Group | $8.44 | 610.9% | → $60 | Reiterates | Buy → Buy | Get Alert |
| 05/25/2023 | ARAV | Buy Now | Aravive | — | — | → $10 | Reiterates | Buy → Buy | Get Alert |
| 05/25/2023 | AGEN | Buy Now | Agenus | $15.56 | -46.66% | → $166 | Assumes | → Buy | Get Alert |
| 05/25/2023 | OCEA | Buy Now | Ocean Biomedical | $1.17 | 1352.99% | → $17 | Assumes | Buy → Buy | Get Alert |
| 05/24/2023 | APGN | Buy Now | Apexigen | — | — | → $0.64 | Downgrade | Buy → Hold | Get Alert |
| 05/24/2023 | CGEN | Buy Now | Compugen | $1.64 | 693.02% | → $13 | Reiterates | Buy → Buy | Get Alert |
| 05/23/2023 | RAIN | Buy Now | Rain Oncology | — | — | $16 → $5 | Downgrade | Buy → Hold | Get Alert |
| 05/16/2023 | GTBP | Buy Now | GT Biopharma | $2.65 | -24.53% | → $60 | Reiterates | Hold → Hold | Get Alert |
| 05/16/2023 | APGN | Buy Now | Apexigen | — | — | $8 → $5 | Maintains | Buy | Get Alert |
| 05/12/2023 | BCAB | Buy Now | BioAtla | $1.37 | 1724.82% | → $25 | Reiterates | Buy → Buy | Get Alert |
| 05/12/2023 | RAIN | Buy Now | Rain Oncology | — | — | → $16 | Reiterates | Buy → Buy | Get Alert |
| 05/11/2023 | ARAV | Buy Now | Aravive | — | — | → $10 | Reiterates | Buy → Buy | Get Alert |
| 05/03/2023 | SVA | Buy Now | Sernova | $5.85 | -14.53% | → $5 | Reiterates | → Buy | Get Alert |
| 04/19/2023 | BCYC | Buy Now | Bicycle Therapeutics | $20.23 | 171.87% | → $55 | Reiterates | → Buy | Get Alert |
| 04/19/2023 | MRUS | Buy Now | Merus | $55.71 | -37.17% | → $35 | Reiterates | → Buy | Get Alert |
| 04/17/2023 | ALLO | Buy Now | Allogene Therapeutics | $2.24 | 569.64% | → $15 | Maintains | Buy | Get Alert |
| 04/17/2023 | ADAP | Buy Now | Adaptimmune Therapeutics | $1.15 | 769.79% | → $10 | Reiterates | → Buy | Get Alert |
| 04/17/2023 | IPSC | Buy Now | Century Therapeutics | $2.30 | 595.65% | → $16 | Maintains | Buy | Get Alert |
| 04/17/2023 | BCAB | Buy Now | BioAtla | $1.37 | 1724.82% | → $25 | Maintains | Buy | Get Alert |
| 04/17/2023 | MRUS | Buy Now | Merus | $55.71 | -37.17% | → $35 | Maintains | Buy | Get Alert |
| 04/17/2023 | INAB | Buy Now | IN8bio | $0.82 | 872.64% | → $8 | Maintains | Buy | Get Alert |
| 04/17/2023 | CRSP | Buy Now | CRISPR Therapeutics | $53.65 | 39.79% | → $75 | Reiterates | → Buy | Get Alert |
| 04/14/2023 | MRUS | Buy Now | Merus | $55.71 | -37.17% | → $35 | Maintains | Buy | Get Alert |
| 04/11/2023 | ADAP | Buy Now | Adaptimmune Therapeutics | $1.15 | 769.79% | → $10 | Reiterates | → Buy | Get Alert |
| 04/03/2023 | CRSP | Buy Now | CRISPR Therapeutics | $53.65 | 39.79% | → $75 | Reiterates | → Buy | Get Alert |
| 03/31/2023 | INAB | Buy Now | IN8bio | $0.82 | 872.64% | → $8 | Reiterates | → Buy | Get Alert |
| 03/31/2023 | GTBP | Buy Now | GT Biopharma | $2.65 | -24.53% | → $60 | Reiterates | → Hold | Get Alert |
| 03/30/2023 | BCEL | Buy Now | Atreca | $0.09 | 11011.11% | → $10 | Reiterates | → Buy | Get Alert |
| 03/29/2023 | INAB | Buy Now | IN8bio | $0.82 | 872.64% | → $8 | Initiates | → Buy | Get Alert |
| 03/24/2023 | BCAB | Buy Now | BioAtla | $1.37 | 1724.82% | → $25 | Reiterates | → Buy | Get Alert |
| 03/23/2023 | TCRR | Buy Now | TCR2 Therapeutics | — | — | → $2 | Reiterates | → Hold | Get Alert |
| 03/16/2023 | IPSC | Buy Now | Century Therapeutics | $2.30 | 595.65% | → $16 | Reiterates | → Buy | Get Alert |
| 03/10/2023 | RAIN | Buy Now | Rain Oncology | — | — | → $16 | Reiterates | → Buy | Get Alert |
| 03/09/2023 | CVM | Buy Now | CEL-SCI | $1.23 | 713.01% | → $10 | Reiterates | → Buy | Get Alert |
| 03/06/2023 | ADAP | Buy Now | Adaptimmune Therapeutics | $1.15 | 769.79% | → $10 | Reiterates | → Buy | Get Alert |
| 03/01/2023 | ALLO | Buy Now | Allogene Therapeutics | $2.24 | 569.64% | → $15 | Reiterates | → Buy | Get Alert |
| 03/01/2023 | MRUS | Buy Now | Merus | $55.71 | -37.17% | → $35 | Reiterates | → Buy | Get Alert |
| 03/01/2023 | FATE | Buy Now | Fate Therapeutics | $3.10 | 222.58% | → $10 | Reiterates | → Buy | Get Alert |
| 02/28/2023 | BCYC | Buy Now | Bicycle Therapeutics | $20.23 | 171.87% | → $55 | Reiterates | → Buy | Get Alert |
| 02/22/2023 | CRSP | Buy Now | CRISPR Therapeutics | $53.65 | 39.79% | → $75 | Reiterates | → Buy | Get Alert |
| 02/17/2023 | CVM | Buy Now | CEL-SCI | $1.23 | 713.01% | → $10 | Assumes | → Buy | Get Alert |
| 02/15/2023 | BCYC | Buy Now | Bicycle Therapeutics | $20.23 | 171.87% | → $55 | Reiterates | → Buy | Get Alert |
| 02/14/2023 | ARAV | Buy Now | Aravive | — | — | → $10 | Maintains | Buy | Get Alert |
| 02/13/2023 | GTHX | Buy Now | G1 Therapeutics | $2.58 | 636.43% | $35 → $19 | Maintains | Buy | Get Alert |
| 01/06/2023 | IPSC | Buy Now | Century Therapeutics | $2.30 | 595.65% | $18 → $16 | Maintains | Buy | Get Alert |
| 01/06/2023 | FATE | Buy Now | Fate Therapeutics | $3.10 | 222.58% | $16 → $10 | Maintains | Buy | Get Alert |
| 01/05/2023 | ADAP | Buy Now | Adaptimmune Therapeutics | $1.15 | 769.79% | → $10 | Initiates | → Buy | Get Alert |
| 01/05/2023 | IPSC | Buy Now | Century Therapeutics | $2.30 | 682.61% | → $18 | Initiates | → Buy | Get Alert |
| 01/05/2023 | RAIN | Buy Now | Rain Oncology | — | — | → $16 | Initiates | → Buy | Get Alert |
| 01/05/2023 | BCAB | Buy Now | BioAtla | $1.37 | 1724.82% | → $25 | Initiates | → Buy | Get Alert |
| 01/05/2023 | ATRA | Buy Now | Atara Biotherapeutics | $7.50 | 233.33% | → $625 | Initiates | → Buy | Get Alert |
| 01/05/2023 | MRUS | Buy Now | Merus | $55.71 | -37.17% | → $35 | Initiates | → Buy | Get Alert |
| 01/05/2023 | ALLO | Buy Now | Allogene Therapeutics | $2.24 | 569.64% | → $15 | Initiates | → Buy | Get Alert |
| 01/05/2023 | BCYC | Buy Now | Bicycle Therapeutics | $20.23 | 171.87% | → $55 | Initiates | → Buy | Get Alert |
| 01/05/2023 | GTHX | Buy Now | G1 Therapeutics | $2.58 | 1256.59% | → $35 | Initiates | → Buy | Get Alert |
| 01/05/2023 | SVA | Buy Now | Sernova | $5.85 | -14.53% | → $5 | Initiates | → Buy | Get Alert |
| 01/05/2023 | GNTA | Buy Now | Genenta Science | $3.40 | 341.18% | → $15 | Initiates | → Buy | Get Alert |
| 01/05/2023 | CGEN | Buy Now | Compugen | $1.64 | 693.02% | → $13 | Initiates | → Buy | Get Alert |
| 01/05/2023 | REPL | Buy Now | Replimune Group | $8.44 | 610.9% | → $60 | Initiates | → Buy | Get Alert |
| 01/05/2023 | FATE | Buy Now | Fate Therapeutics | $3.10 | 416.13% | → $16 | Initiates | → Buy | Get Alert |
| 01/05/2023 | CRSP | Buy Now | CRISPR Therapeutics | $53.65 | 39.79% | → $75 | Initiates | → Buy | Get Alert |
| 01/05/2023 | TCRR | Buy Now | TCR2 Therapeutics | — | — | → $2 | Initiates | → Hold | Get Alert |
| 01/05/2023 | GTBP | Buy Now | GT Biopharma | $2.65 | -24.53% | → $60 | Initiates | → Hold | Get Alert |
| 01/05/2023 | BCEL | Buy Now | Atreca | $0.09 | 11011.11% | → $10 | Initiates | → Buy | Get Alert |
| 01/05/2023 | APGN | Buy Now | Apexigen | — | — | → $8 | Initiates | → Buy | Get Alert |
| 10/20/2022 | AYLA | Buy Now | Ayala Pharmaceuticals | — | — | $14 → $0.55 | Downgrade | Buy → Sell | Get Alert |
| 07/13/2022 | HGEN | Buy Now | Humanigen | $0.00 | 999900% | $13 → $2 | Downgrade | Buy → Neutral | Get Alert |
| 06/02/2022 | RAIN | Buy Now | Rain Oncology | — | — | → $16 | Initiates | → Buy | Get Alert |
| 02/17/2022 | MRKR | Buy Now | Marker Therapeutics | $4.65 | -78.49% | $30 → $10 | Downgrade | Buy → Neutral | Get Alert |
| 11/19/2021 | CMPX | Buy Now | Compass Therapeutics | $0.82 | 1736.21% | — | Initiates | → Buy | Get Alert |
| 08/04/2021 | TBIO | Buy Now | Telesis Bio | $3.98 | 854.77% | $810 → $684 | Maintains | Neutral | Get Alert |
| 07/26/2021 | TBIO | Buy Now | Telesis Bio | $3.98 | 1030.65% | $504 → $810 | Maintains | Buy | Get Alert |
| 06/28/2021 | PBLA | Buy Now | Panbela Therapeutics | $0.37 | 2621.09% | → $240000 | Initiates | → Buy | Get Alert |
| 03/18/2021 | TBIO | Buy Now | Telesis Bio | $3.98 | 603.52% | $666 → $504 | Maintains | Buy | Get Alert |
| 03/17/2021 | GTBP | Buy Now | GT Biopharma | $2.65 | 843.4% | → $750 | Initiates | → Buy | Get Alert |
| 06/18/2019 | TBIO | Buy Now | Telesis Bio | $3.98 | 528.14% | → $450 | Initiates | → Buy | Get Alert |
